Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_890fc771e8fbde93d4ab7a0bd2086b85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_adf225ca4a6bf6190b6a2763410d1ebf http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a29b99f16df7e14981c98d17e921b38c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c86526d92d4a5ad39f4a38a72e66e645 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D253-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J73-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 |
filingDate |
2012-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7000443cdeabcb38f1de58da413103a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72e22a5db3cf04021631bb05b07c16a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1384acd79e0ed328000614863272e846 |
publicationDate |
2014-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2014080796-A1 |
titleOfInvention |
Acetyltanshinone iia (ata) as anticancer agent |
abstract |
The present invention relates to the use of a compound of Formula I for the manufacture of a medicament for treating or preventing cancer in a subject. Formula I |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111000851-A |
priorityDate |
2011-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |